Riot Platforms Stock Gained Momentum in May: AI Rally Explained
Riot Platforms lit up the market in May with a dramatic 57% gain, riding AI computing demand and energy strategy news...
Zero Based Budgeting Success Tips
These tips reinforce discipline, such as setting clear categories, automating transfers, and reviewing results monthly.
17,300 articlesZiff Davis' General Counsel Sale Signals Investor Impact
A senior executive at Ziff Davis sold a sizable block of shares. This article dives into what that move could mean fo...
Costco's 9.8% Same-Store Sales Spark Investor Love Stock
Costco just posted a standout quarter with costco's 9.8% same-store sales showcasing a durable model. This article br...
Jobs Report Released Today Sends Bond Yields Higher
The latest payroll data show a strong labor market, boosting yields and challenging expectations for quick Fed rate c...
Concrete Pumping Holdings Rocketed Amid Market Mayhem
On a day when markets slid on inflation fears, one small-cap stock surprised investors by rocketing higher. Here’s wh...
I’ve Sold Property California’s Central Coast Market Shifts
As remote work persists, demand for ranch and winery estates on California’s Central Coast has shifted from leisure t...
ICLN’s Surge Marks Regime Shift Toward Infrastructure
ICLN has surged about 45% year-to-date, signaling a regime shift from subsidy bets to infrastructure demand. A loomin...
Divorced Americans Derail Retirement: Timing Matters
A new nationwide survey finds 49% of divorced americans derailed retirement plans, underscoring how asset division an...
Judge Stays Lawsuit Seeking Ownership of 40K Bitcoin Wallets
A New York judge has paused a dispute over ownership of about 40,000 bitcoin wallets and scheduled a July hearing on ...
OneTrust’s Gabe Bodner Sells to Affluent Borrowers Now
OneTrust’s Gabe Bodner is shifting reverse mortgage sales toward wealthy retirees, framing the product as a wealth-ma...
Ranking Market’s Bets on OpenAI, Stripe & Consensys IPOs
OpenAI leads the 2026 IPO chatter, with Stripe and Consensys jockeying for position as investors weigh odds, valuatio...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status